Melanoma cells produce multiple laminin isoforms and strongly migrate on α5 laminin(s) via several integrin receptors.
暂无分享,去创建一个
Takako Sasaki | J. Hansson | K. Tryggvason | M. Patarroyo | S. Rodin | A. Domogatskaya | P. Rousselle | Y. Oikawa | Anna Domogatskaya
[1] K. Sekiguchi,et al. Laminin Isoforms Containing the γ3 Chain Are Unable to Bind to Integrins due to the Absence of the Glutamic Acid Residue Conserved in the C-terminal Regions of the γ1 and γ2 Chains* , 2008, Journal of Biological Chemistry.
[2] R. Kramer,et al. Laminin Isoforms of Lymph Nodes and Predominant Role of ␣5- Laminin(s) in Adhesion and Migration of Blood Lymphocytes Physiology and Pharmacology, And , 2022 .
[3] H. Naganuma,et al. Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of α5-laminin(s) and α3β1 integrin , 2007 .
[4] E. Nice,et al. Evidence for a role of tumor-derived laminin-511 in the metastatic progression of breast cancer. , 2007, The American journal of pathology.
[5] C. Lugassy,et al. Angiotropic Melanoma and Extravascular Migratory Metastasis: A Review , 2007, Advances in anatomic pathology.
[6] Alexander Nyström,et al. Laminin isoforms in development and disease , 2007, Journal of Molecular Medicine.
[7] D. Jackson,et al. Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas , 2007, Cell and Tissue Research.
[8] K. Sekiguchi,et al. Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin–integrin interactions using recombinant α3β1, α6β1, α7β1 and α6β4 integrins , 2006 .
[9] K. Tryggvason,et al. Characterization of commercial laminin preparations from human placenta in comparison to recombinant laminins 2 (α2β1γ1), 8 (α4β1γ1), 10 (α5β1γ1) , 2006 .
[10] J. Sanes,et al. A simplified laminin nomenclature. , 2005, Matrix biology : journal of the International Society for Matrix Biology.
[11] K. Sekiguchi,et al. Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration. , 2005, Neoplasia.
[12] J. Miner,et al. Laminin functions in tissue morphogenesis. , 2004, Annual review of cell and developmental biology.
[13] B. Fadeel,et al. An endothelial laminin isoform, laminin 8 (α4β1γ1), is secreted by blood neutrophils, promotes neutrophil migration and extravasation, and protects neutrophils from apoptosis , 2004 .
[14] T. Tsuji. Physiological and Pathological Roles of α3β1 Integrin , 2004, The Journal of Membrane Biology.
[15] Yihai Cao,et al. Deletion of Laminin-8 Results in Increased Tumor Neovascularization and Metastasis in Mice , 2004, Cancer Research.
[16] D. Massi,et al. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. , 2004, Human pathology.
[17] David Polsky,et al. Focus on melanoma. , 2002, Cancer cell.
[18] K. Tryggvason,et al. Chondroitin sulphate modification in the α4 chain of human recombinant laminin-8 (α4β1γ1) , 2002 .
[19] K. Sekiguchi,et al. Localization of Laminin α4-Chain in Developing and Adult Human Tissues , 2002 .
[20] K. Tryggvason,et al. Laminin isoforms in tumor invasion, angiogenesis and metastasis. , 2002, Seminars in cancer biology.
[21] R. Timpl,et al. Recombinant human laminin-10 (alpha5beta1gamma1). Production, purification, and migration-promoting activity on vascular endothelial cells. , 2002, The Journal of biological chemistry.
[22] R. Timpl,et al. Recombinant Human Laminin-10 (α5β1γ1) , 2002, The Journal of Biological Chemistry.
[23] R. Timpl,et al. Domain IVa of laminin α5 chain is cell‐adhesive and binds β1 and αVβ3 integrins through Arg‐Gly‐Asp , 2001 .
[24] P. Meltzer,et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. , 2001, Cancer research.
[25] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[26] C. Lugassy,et al. Melanoma and extravascular migratory metastasis , 2000, Journal of cutaneous pathology.
[27] T. Kiviluoto,et al. Laminin alpha1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues. , 2000, Experimental cell research.
[28] K. Tryggvason,et al. Chain specificity assignment of monoclonal antibodies to human laminins by using recombinant laminin β1 and γ1 chains , 2000 .
[29] R. Kramer,et al. Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[30] M. Marinkovich,et al. Melanocytes adhere to and synthesize laminin‐5 in vitro , 1999, Experimental dermatology.
[31] J. Woodruff,et al. Expression of basement membrane antigens in spindle cell melanoma , 1998, Journal of cutaneous pathology.
[32] K. Sekiguchi,et al. Isolation and Characterization of Laminin-10/11 Secreted by Human Lung Carcinoma Cells , 1998, The Journal of Biological Chemistry.
[33] L. Happerfield,et al. Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas. , 1998, British Journal of Cancer.
[34] V. Morris,et al. An epitope on VLA-6 (alpha6beta1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver. , 1997, Cancer research.
[35] R. Kramer,et al. Laminin 5 deposition promotes keratinocyte motility. , 1996, Experimental cell research.
[36] M. Herlyn,et al. Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. , 1995, Cancer research.
[37] K. Tryggvason,et al. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. , 1995, Cancer research.
[38] D. Noonan,et al. The α3β1 Integrin Is Involved in Melanoma Cell Migration and Invasion , 1995 .
[39] M. Aumailley,et al. Kalinin is more efficient than laminin in promoting adhesion of primary keratinocytes and some other epithelial cells and has a different requirement for integrin receptors , 1994, The Journal of cell biology.
[40] E. Danen,et al. Emergence of α5β1 fibronectin‐ and αvβ3 vitronectin‐receptor expression in melanocytic tumour progression , 1994 .
[41] D. Schadendorf,et al. Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours , 1993, The Journal of pathology.
[42] A. Bartolazzi,et al. Integrin expression in cutaneous malignant melanoma: Association of the α3/β1 heterodimer with tumor progression , 1993 .
[43] P. Natali,et al. Tumor progression in human malignant melanoma is associated with changes in α6/β1 laminin receptor , 1991 .
[44] R. Burgeson,et al. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments , 1991, The Journal of cell biology.
[45] D. Elder,et al. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. , 1990, Cancer research.
[46] R. Kramer,et al. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells. , 1990, Cancer research.
[47] L. Liotta,et al. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. , 1989, The Journal of biological chemistry.
[48] V. Dixit,et al. Production and utilization of extracellular matrix components by human melanocytes. , 1989, Experimental cell research.
[49] E. Kohn,et al. Insulin-like growth factors stimulate chemotaxis in human melanoma cells. , 1988, Biochemical and biophysical research communications.
[50] R. Ruddon,et al. Laminin production by murine melanoma cells: possible involvement in cell motility , 1986, Clinical & Experimental Metastasis.
[51] P. Natali,et al. Distribution of laminin and collagen type‐IV in benign and malignant lesions of melanocytic origin , 1985, International journal of cancer.
[52] L. Liotta,et al. Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. , 1984, Science.
[53] J. McCarthy,et al. Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro , 1984, The Journal of cell biology.
[54] M. Bronner‐Fraser,et al. Abnormalities in neural crest cell migration in laminin alpha5 mutant mice. , 2006, Developmental biology.
[55] M. Bronner‐Fraser,et al. Abnormalities in neural crest cell migration in laminin α5 mutant mice , 2006 .
[56] T. Tsuji. Physiological and pathological roles of alpha3beta1 integrin. , 2004, The Journal of membrane biology.
[57] T. Irimura,et al. Regulation of melanoma cell migration and invasion by laminin-5 and α3β1 integrin (VLA-3) , 2004, Clinical & Experimental Metastasis.
[58] T. Irimura,et al. Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). , 2002, Clinical & experimental metastasis.
[59] R. Kramer,et al. Transfection of MCF-7 carcinoma cells with human integrin alpha7 cDNA promotes adhesion to laminin. , 2001, Archives of biochemistry and biophysics.
[60] R. Cancedda,et al. Melanocytes lie on the epidermal basement membrane where they closely interact with surrounding basal ker- atinocytes to form a functional structure defined as the epi- dermal-melanin unit (Weiss and Greep, 1977). Melanocytes protect keratinocytes against ultraviolet damage (such as photocarcinogene , 1999 .
[61] D. Noonan,et al. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. , 1995, Experimental cell research.
[62] A. Sonnenberg,et al. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins. , 1993, Cell adhesion and communication.
[63] A. Bartolazzi,et al. Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression. , 1993, International journal of cancer.
[64] P. Natali,et al. Tumor progression in human malignant melanoma is associated with changes in alpha 6/beta 1 laminin receptor. , 1991, International journal of cancer.